Long Covid Symptom Clusters, Correlates and Predictors in a Highly Vaccinated Australian Population in 2023
- PMID: 40342248
- PMCID: PMC12059467
- DOI: 10.1111/hex.70273
Long Covid Symptom Clusters, Correlates and Predictors in a Highly Vaccinated Australian Population in 2023
Abstract
Background: Limited data exists regarding long Covid burden following Omicron infection in highly vaccinated populations.
Objective: To (1) characterise long Covid prevalence and predictors and (2) identify key symptom clusters and their correlates among long Covid patients, during an Omicron-predominant period in a highly vaccinated population.
Design: Anonymous, online, cross-sectional survey.
Setting: January 2023, Australia.
Participants: Residents aged ≥ 18 years with self-reported history of test-positive Covid-19. The main variables studied were socio-demographic characteristics, Covid-19 risk factors, vaccination, infection history and experiences with long Covid.
Main outcome measures: Long Covid symptoms. Symptom-based clustering was used to identify long Covid symptom clusters and their functional correlates. Predictors of long Covid occurrence and severity were assessed using multivariable logistic regression.
Results: Overall, 240/1205 participants (19.9%) reported long Covid. Long Covid risk was significantly higher for women OR 1.71 (95% CI: 1.17-2.51), people with comorbidities 2.19 (95% CI: 1.56-3.08) and those using steroid inhalers for Covid-19 treatment (2.34 [95% CI: 1.29-4.24]). Long-Covid risk increased with increasing Covid-19 infection severity (moderately severe symptoms: 2.23 [95% CI: 1.50-3.30], extremely severe symptoms: 5.80 [95% CI: 3.48-9.66], presented to ED/hospitalised: 7.22 [95% CI: 3.06-17.03]). We found no significant difference in the likelihood of long Covid between the Omicron and pre-Omicron periods, vaccination status and participant age. We identified two long Covid clusters (pauci-symptomatic, n = 170, vs. polysymptomatic, n = 66). Polysymptomatic cluster membership was associated with worse functioning (impacts on work, moderate activity, emotions and energy). Severity acute infection was strongly predictive of polysymptomatic cluster membership (5.72 [2.04-17.58]). Monoclonal antibody treatment was strongly associated with pauci-symptomatic cluster membership (0.02 [0.00-0.13]).
Discussion: Our study shows that long Covid is an important health burden in Australia, including during the Omicron era, and identifies several risk factors. We found a subgroup of patients characterised by more symptoms and worse functional outcomes. Our findings can inform policies for protecting vulnerable populations and frameworks for long Covid risk assessment and management.
Conclusions: One-in-five people may suffer long Covid after acute Covid-19 infection, with similar risk across age groups. Omicron variants appear not to have a lower risk compared to earlier variants in our study. A cumulative number of symptoms can help triage long Covid patients.
Patient or public contribution: We did not involve patients or the public in the design of the questionnaire. However, after a soft launch, we revised some survey questions by reviewing early responses from patients and the public.
Keywords: Australia; Covid‐19; Omicron; SARS‐CoV‐2; long Covid.
© 2025 The Author(s). Health Expectations published by John Wiley & Sons Ltd.
Conflict of interest statement
E.T., R.C., D.A.H., R.D., M.K., A.N., H.S. and D.A. authors declare no conflicts of interest. D.G. is a member of OzSAGE. C.R.M. is on the WHO COVID‐19 Vaccine Composition Technical Advisory Group and the WHO SAGE Working Group on Smallpox and Monkeypox. She receives funding from Sanofi for influenza and pertussis research and from NHMRC and MRFF.
Figures





Similar articles
-
SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.J Infect. 2023 Dec;87(6):506-515. doi: 10.1016/j.jinf.2023.08.009. Epub 2023 Sep 28. J Infect. 2023. PMID: 37777159
-
Long COVID in a highly vaccinated but largely unexposed Australian population following the 2022 SARS-CoV-2 Omicron wave: a cross-sectional survey.Med J Aust. 2024 Apr 1;220(6):323-330. doi: 10.5694/mja2.52256. Epub 2024 Mar 20. Med J Aust. 2024. PMID: 38508863
-
Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.JAMA. 2022 Oct 18;328(15):1523-1533. doi: 10.1001/jama.2022.18550. JAMA. 2022. PMID: 36255426 Free PMC article.
-
Prevalence and impact of persistent symptoms following SARS-CoV-2 infection among healthcare workers: A cross-sectional survey in the SIREN cohort.J Infect. 2024 Oct;89(4):106259. doi: 10.1016/j.jinf.2024.106259. Epub 2024 Aug 28. J Infect. 2024. PMID: 39214242
-
Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis.BMC Infect Dis. 2025 Feb 13;25(1):215. doi: 10.1186/s12879-025-10610-5. BMC Infect Dis. 2025. PMID: 39948450 Free PMC article.
References
-
- World Health Organization . “A Clinical Case Definition of Post COVID‐19 Condition by a Delphi Consensus,” retrieved November 6, 2022, https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_cond....
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous